References
- National Cancer Institute. Prostate Cancer (PDQ). Treatment—Health Professionals. CancerNet. A Service of the National Cancer Institute, http://cancernet.nci.nih.gov (accessed December 1999)
- Stanford J. L., Feng Z., Hamilton A. S., Gilliland F. D., Stephenson R. A., Eley J. W., Albertsen P. C., Harlan L. C., Potosky A. L. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer. The prostate cancer outcomes study. JAMA 2000; 283(3)354–360, [PUBMED], [INFOTRIEVE]
- Walsh P. C., Marschke P., Ricker D., Burnett A. L. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 2000; 55(1)58–61, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Catalona W. J., Carvalhal G. F., Mager D. E., Smith D. S. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J. Urol. 1999; 162(2)433–438, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Borghede G., Hedelin H. Radiotherapy of localised prostate cancer. Analysis of late treatment complications. A prospective study. Radiother. Oncol. 1997; 43(2)139–146, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Incrocci L., Slob A. K., Levendag P. C. Sexual (dys)function after radiotherapy for prostate cancer: a review. Int. J. Radiat. 2002; 52(3)681–693, [CROSSREF], [CSA]
- Zelefsky M. J., Cowen D., Fuks Z., Shike M., Burman C., Jackson A., Venkatramen E. S., Leibel S. A. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 1999; 85(11)2460–2468, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Helgason A. R., Fredrikson M., Adolfsson J., Steineck G. Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life. Int. J. Radiat. Oncol. Biol. Phys. 1995; 32(1)33–39, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Shipley W. U., Prout G. R., Jr., Coachman N. M., McManus P. L., Healey E. A., Althausen A. F., Heney N. M., Parkhurst E. C., Young H. H., II, Shipley J. W., et al. Radiation therapy for localized prostate carcinoma: experience at the Massachusetts General Hospital (1973–1981). NCI Monogr. 1988, 7: 67–73
- Fransson P., Widmark A. Self-assessed sexual function after pelvic irradiation for prostate carcinoma. Comparison with an age-matched control group. Cancer 1996; 78(5)1066–1078, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Fransson P., Widmark A. Late side-effects unchanged 4–8 years after radiotherapy for prostate carcinoma: a comparison with age-matched controls. Cancer 1999; 85(3)678–688, [PUBMED], [INFOTRIEVE]
- Turner S. L., Adams K., Bull C. A., Berry M. P. Sexual dysfunction after radical radiation therapy for prostate cancer: a prospective evaluation. Urology 1999; 54(1)124–129, [PUBMED], [INFOTRIEVE], [CROSSREF]
- DeLaney T. F., Shipley W. U., O'Leary M. P., Biggs P. J., Prout G. R., Jr. Preoperative irradiation, lymphadenectomy, and 125iodine implantation for patients with localized carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 1986; 12(10)1779–1785, [PUBMED], [INFOTRIEVE]
- Talcott J. A., Clark J. A., Stark P. C., Mitchell S. P. Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated. J. Urol. 2001; 166(2)494–499, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Merrick G. S., Wallner K. E., Butler W. M. Management of sexual dysfunction after prostate brachytherapy. Oncology (Huntington) 2003; 17(1)52–62, discussion 62, 67–70, 73[CSA]
- Wallner K., Roy J., Zelefsky M., Fuks Z., Harrison L. Short-term freedom from disease progression after I-125 prostate implantation. Int. J. Radiat. Oncol. Biol. Phys. 1994; 30(2)405–409, [PUBMED], [INFOTRIEVE], [CSA]
- Stock R. G., Stone N. N., Iannuzzi C. Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 1996; 35(2)267–272, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Stock R. G., Stone N. N., DeWyngaert J. K., Lavagnini P., Unger P. D. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma. Cancer 1996; 77(11)2386–2392, [PUBMED], [INFOTRIEVE]
- Lim A. J., Brandon A. H., Fiedler J., Brickman A. L., Boyer C. I., Raub W. A., Jr., Soloway M. S. Quality of life: radical prostatectomy versus radiation therapy for prostate cancer. J. Urol. 1995; 154(4)1420–1425, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Litwin M. S., Flanders S. C., Pasta D. J., Stoddard M. L., Lubeck D. P., Henning J. M. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the prostate strategic urologic research endeavor. Urology 1999; 54(3)503–508, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Litwin M. S., Hays R. D., Fink A., Ganz P. A., Leake B., Leach G. E., Brook R. H. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995; 273(2, Jan 11)129–135, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Litwin M. S., McGuigan K. A., Shpall A. I., Dhanani N. Recovery of health related quality of life in the year after radical prostatectomy: early experience. J. Urol. 1999; 161(2)515–519, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Brandeis J. M., Litwin M. S., Burnison C. M., Reiter R. E. Quality of life outcomes after brachytherapy for early stage prostate cancer. J. Urol. 2000; 163(3)851–857, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Krongrad A., Litwin M. S., Lai H., Lai S. Dimensions of quality of life in prostate cancer. J. Urol. 1998; 160(3 Pt 1)807–810, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Clark J. A., Rieker P., Propert K. J., Talcott J. A. Changes in quality of life following treatment for early prostate cancer. Urology 1999; 53(1)161–168, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wei J. T., Dunn R. L., Sandler H. M., McLaughlin P. W., Montie J. E., Litwin M. S., Nyquist L., Sanda M. G. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J. Clin. Oncol. 2002; 20(2)557–566, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bacon C. G., Giovannucci E., Testa M., Glass T. A., Kawachi I. The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients. Cancer 2002; 94(3)862–871, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bokhour B. G., Clark J. A., Inui T. S., Silliman R. A., Talcott J. A. Sexuality after treatment for early prostate cancer: exploring the meanings of “erectile dysfunction”. J. Gen. Int. Med. 2001; 16(10)649–655, [CSA]
- Bertero C. Altered sexual patterns after treatment for prostate cancer. Cancer Pract. 2001; 9(5)245–251, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fergus K. D., Gray R. E., Fitch M. I. Sexual dysfunction and the preservation of manhood: experiences of men with prostate cancer. J. Health Psychol. 2002; 7(3)303–316, [CROSSREF]
- Steginga S. K., Occhipinti S., Gardiner R. A., Yaxley J., Heathcote P. Making decisions about treatment for localized prostate cancer. BJU Int. 2002; 89(3)255–260, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Volk R. J., Cantor S. B., Spann S. J., Cass A. R., Cardenas M. P., Warren M. M. Preferences of husbands and wives for prostate cancer screening. Arch. Fam. Med. 1997; 6(1)72–76, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Davison B. J., Gleave M. E., Goldenberg S. L., Degner L. F., Hoffart D., Berkowitz J. Assessing information and decision preferences of men with prostate cancer and their partners. Cancer Nurs. 2002; 25(1)42–49, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Boehmer U., Babayan R. A pilot study to determine support during the pre-treatment phase of early prostate cancer. Psycho-Oncology, in press
- Strauss A., Corbin J. Basics of Qualitative Research: Grounded Theory Procedures and Techniques. Sage, Newbury Park, CA 1990
- Litwin M. S., Nied R. J., Dhanani N. Health-related quality of life in men with erectile dysfunction. J. Gen. Int. Med. 1998; 13(3)159–166, [CROSSREF], [CSA]